- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 17th, 2007
Tampa's TransGenex names Lucas CEO, president
TransGenex Nanobiotech Inc. has named John E. Lucas CEO and president.
Formerly chairman and CEO of EpiCept Corp., Lucas has also had experience with startups.
TransGenex is developing novel nanoparticle platform technologies to diagnose and treat a number of diseases. The company licensed its patents from the University of South Florida.
|Related News Press|
The NanoWizardŽ AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016
Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016
Nanometrics Reports Second Quarter 2016 Financial Results July 26th, 2016
Ultrasensitive sensor using N-doped graphene July 26th, 2016
Research team led by NUS scientists develop plastic flexible magnetic memory device: Novel technique to implant high-performance magnetic memory chip on a flexible plastic surface without compromising performance July 21st, 2016